Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)

International Retina Biosimilar Study Group (Inter BIOS Group)

doi:10.1038/s41433-024-03220-z

Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)

International Retina Biosimilar Study Group (Inter BIOS Group)

Ophthalmology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	3193-3196
Number of pages	4
Journal	Eye (Basingstoke)
Volume	38
Issue number	16
DOIs	https://doi.org/10.1038/s41433-024-03220-z
State	Published - Nov 2024

Access to Document

10.1038/s41433-024-03220-z

Cite this

@article{d1e04ff8de6644d9bc1cb631d5c5788a,

title = "Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)",

author = "{International Retina Biosimilar Study Group (Inter BIOS Group)} and Tomoko Ueda-Consolvo and Masaaki Ishida and Tomoko Nakamura and Shuichiro Yanagisawa and Kotaro Tsuboi and Taku Wakabayashi and Atsushi Hayashi and Ashish Sharma and Zinkernage, {Martin S.} and Martin Splitzer and Francesc March and Grewal, {Dilraj S.} and David Eichenbaum and Jayanth Sridhar and Tarek Hassan and Keane, {Pearse A.} and DO, {Diana V.} and Nguyen, {Quan Dong} and Prithvi Mruthyunjaya and Barbara Parolini and Valentina Sarao and Wintergerst, {Maximilian W.M.} and Tunde Peto and Aleksandra Rachitskaya and David Boyer and Assaf Hilely and Giulia Corradetti and Nicolas Yannuzzi and Adnan Tufail and Taiji Sakamoto and Nancy Holekemp and Caroline Baumal and Paolo Lanzetta and Alper Bilgic and Kodjikian Laurent and {\c S}eng{\"u}l {\"O}zdek and Giuseppe Querques and David Sarraf and Sobha Sivaprasad and Holz, {Frank G.} and Ramin Tadayoni and Kaiser, {Peter K.} and Khanani, {Arshad M.} and Rezaei, {Kourous A.} and Alay Banker and Debdulal Chakraborty and Chitaranjan Mishra and Seemantini Ayachit and Jay Sheth and Anat Loewenstein",

year = "2024",

month = nov,

doi = "10.1038/s41433-024-03220-z",

language = "אנגלית",

volume = "38",

pages = "3193--3196",

journal = "Eye (Basingstoke)",

issn = "0950-222X",

publisher = "Nature Publishing Group",

number = "16",

}

TY - JOUR

T1 - Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)

AU - International Retina Biosimilar Study Group (Inter BIOS Group)

AU - Ueda-Consolvo, Tomoko

AU - Ishida, Masaaki

AU - Nakamura, Tomoko

AU - Yanagisawa, Shuichiro

AU - Tsuboi, Kotaro

AU - Wakabayashi, Taku

AU - Hayashi, Atsushi

AU - Sharma, Ashish

AU - Zinkernage, Martin S.

AU - Splitzer, Martin

AU - March, Francesc

AU - Grewal, Dilraj S.

AU - Eichenbaum, David

AU - Sridhar, Jayanth

AU - Hassan, Tarek

AU - Keane, Pearse A.

AU - DO, Diana V.

AU - Nguyen, Quan Dong

AU - Mruthyunjaya, Prithvi

AU - Parolini, Barbara

AU - Sarao, Valentina

AU - Wintergerst, Maximilian W.M.

AU - Peto, Tunde

AU - Rachitskaya, Aleksandra

AU - Boyer, David

AU - Hilely, Assaf

AU - Corradetti, Giulia

AU - Yannuzzi, Nicolas

AU - Tufail, Adnan

AU - Sakamoto, Taiji

AU - Holekemp, Nancy

AU - Baumal, Caroline

AU - Lanzetta, Paolo

AU - Bilgic, Alper

AU - Laurent, Kodjikian

AU - Özdek, Şengül

AU - Querques, Giuseppe

AU - Sarraf, David

AU - Sivaprasad, Sobha

AU - Holz, Frank G.

AU - Tadayoni, Ramin

AU - Kaiser, Peter K.

AU - Khanani, Arshad M.

AU - Rezaei, Kourous A.

AU - Banker, Alay

AU - Chakraborty, Debdulal

AU - Mishra, Chitaranjan

AU - Ayachit, Seemantini

AU - Sheth, Jay

AU - Loewenstein, Anat

PY - 2024/11

Y1 - 2024/11

UR - http://www.scopus.com/inward/record.url?scp=85199612115&partnerID=8YFLogxK

U2 - 10.1038/s41433-024-03220-z

DO - 10.1038/s41433-024-03220-z

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 39043816

AN - SCOPUS:85199612115

SN - 0950-222X

VL - 38

SP - 3193

EP - 3196

JO - Eye (Basingstoke)

JF - Eye (Basingstoke)

IS - 16

ER -

Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)

Access to Document

Other files and links

Cite this